Phytochemicals as Potential Chemopreventive and Chemotherapeutic Agents for Emerging Human Papillomavirus–Driven Head and Neck Cancer: Current Evidence and Future Prospects

Head and neck cancer (HNC) usually arises from squamous cells of the upper aerodigestive tract that line the mucosal surface in the head and neck region. In India, HNC is common in males, and it is the sixth most common cancer globally. Conventionally, HNC attributes to the use of alcohol or chewing...

Full description

Bibliographic Details
Main Authors: Nikita Aggarwal, Joni Yadav, Suhail Chhakara, Divya Janjua, Tanya Tripathi, Apoorva Chaudhary, Arun Chhokar, Kulbhushan Thakur, Tejveer Singh, Alok Chandra Bharti
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.699044/full
_version_ 1818922504492679168
author Nikita Aggarwal
Joni Yadav
Suhail Chhakara
Divya Janjua
Tanya Tripathi
Apoorva Chaudhary
Arun Chhokar
Kulbhushan Thakur
Tejveer Singh
Alok Chandra Bharti
author_facet Nikita Aggarwal
Joni Yadav
Suhail Chhakara
Divya Janjua
Tanya Tripathi
Apoorva Chaudhary
Arun Chhokar
Kulbhushan Thakur
Tejveer Singh
Alok Chandra Bharti
author_sort Nikita Aggarwal
collection DOAJ
description Head and neck cancer (HNC) usually arises from squamous cells of the upper aerodigestive tract that line the mucosal surface in the head and neck region. In India, HNC is common in males, and it is the sixth most common cancer globally. Conventionally, HNC attributes to the use of alcohol or chewing tobacco. Over the past four decades, portions of human papillomavirus (HPV)-positive HNC are increasing at an alarming rate. Identification based on the etiological factors and molecular signatures demonstrates that these neoplastic lesions belong to a distinct category that differs in pathological characteristics and therapeutic response. Slow development in HNC therapeutics has resulted in a low 5-year survival rate in the last two decades. Interestingly, HPV-positive HNC has shown better outcomes following conservative treatments and immunotherapies. This raises demand to have a pre-therapy assessment of HPV status to decide the treatment strategy. Moreover, there is no HPV-specific treatment for HPV-positive HNC patients. Accumulating evidence suggests that phytochemicals are promising leads against HNC and show potential as adjuvants to chemoradiotherapy in HNC. However, only a few of these phytochemicals target HPV. The aim of the present article was to collate data on various leading phytochemicals that have shown promising results in the prevention and treatment of HNC in general and HPV-driven HNC. The review explores the possibility of using these leads against HPV-positive tumors as some of the signaling pathways are common. The review also addresses various challenges in the field that prevent their use in clinical settings.
first_indexed 2024-12-20T01:54:36Z
format Article
id doaj.art-c97dadf647484c5ca177cb03d8750dd9
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-20T01:54:36Z
publishDate 2021-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-c97dadf647484c5ca177cb03d8750dd92022-12-21T19:57:32ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-07-011210.3389/fphar.2021.699044699044Phytochemicals as Potential Chemopreventive and Chemotherapeutic Agents for Emerging Human Papillomavirus–Driven Head and Neck Cancer: Current Evidence and Future ProspectsNikita AggarwalJoni YadavSuhail ChhakaraDivya JanjuaTanya TripathiApoorva ChaudharyArun ChhokarKulbhushan ThakurTejveer SinghAlok Chandra BhartiHead and neck cancer (HNC) usually arises from squamous cells of the upper aerodigestive tract that line the mucosal surface in the head and neck region. In India, HNC is common in males, and it is the sixth most common cancer globally. Conventionally, HNC attributes to the use of alcohol or chewing tobacco. Over the past four decades, portions of human papillomavirus (HPV)-positive HNC are increasing at an alarming rate. Identification based on the etiological factors and molecular signatures demonstrates that these neoplastic lesions belong to a distinct category that differs in pathological characteristics and therapeutic response. Slow development in HNC therapeutics has resulted in a low 5-year survival rate in the last two decades. Interestingly, HPV-positive HNC has shown better outcomes following conservative treatments and immunotherapies. This raises demand to have a pre-therapy assessment of HPV status to decide the treatment strategy. Moreover, there is no HPV-specific treatment for HPV-positive HNC patients. Accumulating evidence suggests that phytochemicals are promising leads against HNC and show potential as adjuvants to chemoradiotherapy in HNC. However, only a few of these phytochemicals target HPV. The aim of the present article was to collate data on various leading phytochemicals that have shown promising results in the prevention and treatment of HNC in general and HPV-driven HNC. The review explores the possibility of using these leads against HPV-positive tumors as some of the signaling pathways are common. The review also addresses various challenges in the field that prevent their use in clinical settings.https://www.frontiersin.org/articles/10.3389/fphar.2021.699044/fullhead and neck cancerhuman pappillomavirustobaccosmokingphytochemicalstherapeutics
spellingShingle Nikita Aggarwal
Joni Yadav
Suhail Chhakara
Divya Janjua
Tanya Tripathi
Apoorva Chaudhary
Arun Chhokar
Kulbhushan Thakur
Tejveer Singh
Alok Chandra Bharti
Phytochemicals as Potential Chemopreventive and Chemotherapeutic Agents for Emerging Human Papillomavirus–Driven Head and Neck Cancer: Current Evidence and Future Prospects
Frontiers in Pharmacology
head and neck cancer
human pappillomavirus
tobacco
smoking
phytochemicals
therapeutics
title Phytochemicals as Potential Chemopreventive and Chemotherapeutic Agents for Emerging Human Papillomavirus–Driven Head and Neck Cancer: Current Evidence and Future Prospects
title_full Phytochemicals as Potential Chemopreventive and Chemotherapeutic Agents for Emerging Human Papillomavirus–Driven Head and Neck Cancer: Current Evidence and Future Prospects
title_fullStr Phytochemicals as Potential Chemopreventive and Chemotherapeutic Agents for Emerging Human Papillomavirus–Driven Head and Neck Cancer: Current Evidence and Future Prospects
title_full_unstemmed Phytochemicals as Potential Chemopreventive and Chemotherapeutic Agents for Emerging Human Papillomavirus–Driven Head and Neck Cancer: Current Evidence and Future Prospects
title_short Phytochemicals as Potential Chemopreventive and Chemotherapeutic Agents for Emerging Human Papillomavirus–Driven Head and Neck Cancer: Current Evidence and Future Prospects
title_sort phytochemicals as potential chemopreventive and chemotherapeutic agents for emerging human papillomavirus driven head and neck cancer current evidence and future prospects
topic head and neck cancer
human pappillomavirus
tobacco
smoking
phytochemicals
therapeutics
url https://www.frontiersin.org/articles/10.3389/fphar.2021.699044/full
work_keys_str_mv AT nikitaaggarwal phytochemicalsaspotentialchemopreventiveandchemotherapeuticagentsforemerginghumanpapillomavirusdrivenheadandneckcancercurrentevidenceandfutureprospects
AT joniyadav phytochemicalsaspotentialchemopreventiveandchemotherapeuticagentsforemerginghumanpapillomavirusdrivenheadandneckcancercurrentevidenceandfutureprospects
AT suhailchhakara phytochemicalsaspotentialchemopreventiveandchemotherapeuticagentsforemerginghumanpapillomavirusdrivenheadandneckcancercurrentevidenceandfutureprospects
AT divyajanjua phytochemicalsaspotentialchemopreventiveandchemotherapeuticagentsforemerginghumanpapillomavirusdrivenheadandneckcancercurrentevidenceandfutureprospects
AT tanyatripathi phytochemicalsaspotentialchemopreventiveandchemotherapeuticagentsforemerginghumanpapillomavirusdrivenheadandneckcancercurrentevidenceandfutureprospects
AT apoorvachaudhary phytochemicalsaspotentialchemopreventiveandchemotherapeuticagentsforemerginghumanpapillomavirusdrivenheadandneckcancercurrentevidenceandfutureprospects
AT arunchhokar phytochemicalsaspotentialchemopreventiveandchemotherapeuticagentsforemerginghumanpapillomavirusdrivenheadandneckcancercurrentevidenceandfutureprospects
AT kulbhushanthakur phytochemicalsaspotentialchemopreventiveandchemotherapeuticagentsforemerginghumanpapillomavirusdrivenheadandneckcancercurrentevidenceandfutureprospects
AT tejveersingh phytochemicalsaspotentialchemopreventiveandchemotherapeuticagentsforemerginghumanpapillomavirusdrivenheadandneckcancercurrentevidenceandfutureprospects
AT alokchandrabharti phytochemicalsaspotentialchemopreventiveandchemotherapeuticagentsforemerginghumanpapillomavirusdrivenheadandneckcancercurrentevidenceandfutureprospects